Korean Medicine-Based Drug Repositioning Cancer Research Center (KDCRC) is discovering a new Korean Medicine based drug that is effective for treatment and prevention of cancer management of adverse events through reinterpretation of Korean Medicinals and utilizing existing drug development methods. Through reinterpretation of Korean Medicinals that has been used for various symptoms and diseases and new application of these drugs to cancer patiens, we expect to develop successful cancer treatments
Our Korean Medicine-Based Drug Repositioning Cancer Research Center aims to discover and reconstruct herbal medicines through profound medical research. As cancer is a leading cause of death worldwide, the center's goal is to develop drugs for cancer treatment, prevention, and management.
As life expectancy increases and the population ages, cancer patients continue to rise; hence, the development of cancer treatments is also becoming exceptionally vital.
With that said, it is our utmost priority to develop effective cancer treatments by reinterpreting and repositioning herbal medicines for cancer patients.
Based on our center's research, we hope to promote overall health, develop new anticancer drugs, and strengthen the competitiveness of our traditional Korean medicine. KDCRC aims to lead research and development of Korean Medicine based cancer treatment drug through reinterpretation KDCRC aims to improve the quality of people’s lives through Korean Medicine as a future growth engine 1. Discovering a new Korean medicine based drug with direct tumor suppressor effect and autophagy
2. Discovering Korean medicine based drug that can control the microenvironment of tumor inflammation
3. Developing, researching, and establishing conditions for administrating Korean medicine based drug with management capability for chemotherapy-related adverse events 1. Research on circulation map
2. Joint seminar
3. International Symposium
4. Korean Medicine MRC Conference and Periodic Seminar
5. International collaborative research